BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25562615)

  • 1. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db/db mice.
    Plante E; Menaouar A; Danalache BA; Yip D; Broderick TL; Chiasson JL; Jankowski M; Gutkowska J
    Endocrinology; 2015 Apr; 156(4):1416-28. PubMed ID: 25562615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy.
    Gutkowska J; Broderick TL; Bogdan D; Wang D; Lavoie JM; Jankowski M
    J Physiol; 2009 Oct; 587(Pt 19):4725-36. PubMed ID: 19675071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice.
    Manolescu DC; Jankowski M; Danalache BA; Wang D; Broderick TL; Chiasson JL; Gutkowska J
    Appl Physiol Nutr Metab; 2014 Oct; 39(10):1127-36. PubMed ID: 25017112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice.
    Plante E; Menaouar A; Danalache BA; Broderick TL; Jankowski M; Gutkowska J
    Diabetologia; 2014 Jun; 57(6):1257-67. PubMed ID: 24595856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin and cardioprotection in diabetes and obesity.
    Jankowski M; Broderick TL; Gutkowska J
    BMC Endocr Disord; 2016 Jun; 16(1):34. PubMed ID: 27268060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in mice with monogenic obesity: the db/db mouse and its use in the study of cardiac consequences.
    Belke DD; Severson DL
    Methods Mol Biol; 2012; 933():47-57. PubMed ID: 22893400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice.
    Fujita H; Fujishima H; Koshimura J; Hosoba M; Yoshioka N; Shimotomai T; Morii T; Narita T; Kakei M; Ito S
    Endocr J; 2005 Aug; 52(4):427-33. PubMed ID: 16127210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
    He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
    Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers.
    Trousdale RK; Jacobs S; Simhaee DA; Wu JK; Lustbader JW
    J Surg Res; 2009 Jan; 151(1):100-7. PubMed ID: 18619614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
    Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
    J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
    Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hypertrophic effects of oxytocin in rat ventricular myocytes.
    Menaouar A; Florian M; Wang D; Danalache B; Jankowski M; Gutkowska J
    Int J Cardiol; 2014 Jul; 175(1):38-49. PubMed ID: 24852833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
    Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
    Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse.
    Broderick TL; Jankowski M; Gutkowska J
    Diabetes Metab Syndr Obes; 2017; 10():27-36. PubMed ID: 28138261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus.
    Silva MA; Cau SB; Lopes RA; Manzato CP; Neves KB; Bruder-Nascimento T; Mestriner FL; Montezano AC; Nguyen Dinh Cat A; Touyz RM; Tostes RC
    Clin Sci (Lond); 2015 Oct; 129(7):533-45. PubMed ID: 25967696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia promotes myocardial dysfunction via the ERS-MAPK10 signaling pathway in db/db mice.
    Deng YW; Liu F; Li ZT; Gao JH; Zhao Y; Yang XL; Xia YL
    Lab Invest; 2022 Nov; 102(11):1192-1202. PubMed ID: 35941186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.